COVID-19 and for protection of those who have never had the infection and are not immune.”

Xianglei Liu of Pitt is also co-lead author of the study.

Researchers are “thinking outside the box” for how the drug could be administered, stating it may be able to be inhaled or through a superficial injection, instead of an IV.